Globus Medical entered into an agreement to acquire the ex-U.S. operations and distribution channels of Alphatec (ATEC) for US $80.0MM in cash. ATEC posted 2015 ex-U.S. revenue of $70.7MM.
Pluristem Therapeutics intends to conduct a U.S./EUÂ Phase III trial assessing use of PLX-PAD (PLacental eXpanded)Â cells to support recovery following surgery for femoral neck fracture.
Data from a 12-month study of 1-level ACDF patients treated with Trinity Evolution® + a PEEK interbody spacer demonstrated fusion rates of 78.6% at 6 months and 93.5% at one year.
Intellirod Spine raised >US $1.0MM in additional equity financing. Funds will be used to reach key milestones toward commercialization of sensor technologies and lumbar fusion implants.Â
Ortho Kinematics launched VMA-Align, a diagnostic module that provides detailed spinal alignment measurements within the Vertebral Motion Analysis (VMA) product. The data is intended to assist in patient selection and planning for lumbar fusion.
Zimmer Biomet commenced limited U.S. launch of Signature Solutions™, clinical services and technologies to assist hospitals and medical practices with the transition to value-based healthcare models.
Pre-clinical studies suggest that multipotent adult progenitor cells (MAPCs), such as the technology used in RTI Surgical’s map3® Cellular Allogeneic Bone Grafts, exhibited a more robust angiogenic protein release profile vs. mesenchymal stem cells in vitro.